DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $483,971 | -1.6% | 45,486 | -3.7% | 0.00% | 0.0% |
Q3 2022 | $492,000 | -30.6% | 47,219 | -16.1% | 0.00% | 0.0% |
Q2 2022 | $709,000 | +10.8% | 56,310 | -4.7% | 0.00% | – |
Q1 2022 | $640,000 | -10.0% | 59,070 | +16.8% | 0.00% | – |
Q4 2021 | $711,000 | +115.5% | 50,570 | -46.0% | 0.00% | – |
Q1 2020 | $330,000 | -39.3% | 93,569 | -1.6% | 0.00% | – |
Q4 2019 | $544,000 | +30.8% | 95,072 | +353.7% | 0.00% | – |
Q1 2018 | $416,000 | -45.7% | 20,955 | -48.8% | 0.00% | -100.0% |
Q4 2017 | $766,000 | -14.2% | 40,942 | -1.5% | 0.00% | 0.0% |
Q3 2017 | $893,000 | +9.8% | 41,552 | -50.7% | 0.00% | 0.0% |
Q2 2017 | $813,000 | +90.8% | 84,217 | +17.5% | 0.00% | – |
Q1 2017 | $426,000 | +49.5% | 71,648 | -0.5% | 0.00% | – |
Q4 2016 | $285,000 | -66.7% | 72,033 | -11.6% | 0.00% | -100.0% |
Q3 2016 | $855,000 | -50.1% | 81,467 | -30.7% | 0.00% | -50.0% |
Q2 2016 | $1,713,000 | -14.3% | 117,492 | +13.1% | 0.00% | 0.0% |
Q1 2016 | $1,998,000 | +11.1% | 103,866 | +39.5% | 0.00% | 0.0% |
Q4 2015 | $1,799,000 | -2.8% | 74,461 | -1.2% | 0.00% | 0.0% |
Q3 2015 | $1,850,000 | – | 75,373 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 454,881 | $6,632,000 | 5.71% |
CLOVIS CAPITAL MANAGEMENT LP | 416,397 | $6,071,000 | 2.81% |
Amici Capital, LLC | 1,016,002 | $14,813,000 | 2.79% |
Vivo Capital, LLC | 359,828 | $5,246,000 | 1.43% |
DSC Advisors, L.P. | 155,000 | $2,260,000 | 1.42% |
GLENHILL ADVISORS LLC | 1,288,771 | $18,791,000 | 1.36% |
Cormorant Asset Management, LP | 635,000 | $9,258,000 | 1.31% |
Senvest Management, LLC | 997,731 | $14,547,000 | 1.19% |
Claar Advisors LLC | 125,000 | $1,823,000 | 0.90% |
Hatteras Investment Partners, LP | 10,590 | $154,000 | 0.86% |